⚠️ Uptrend Under Pressure Severe risk · 99 · Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY) Full briefing → Jul 28
Simple research view

LLY · Eli Lilly and Company

$1197.53 latest stored close
Detected setup Cup & Handle

Watch · Quality 22/100

Ask about LLY

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

Scans / Health Technology / LLY

$LLY

Eli Lilly and Company

Eli Lilly and Company is a mega-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $1.1T.

Strong Buy · 87 Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 2 Data 58m ago
$1197.53 latest close
← Back Join to Watchlist $LLY Share card
Council read · 6 methods

Watch — evidence is building

0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.

Review six verdicts Inspect chart
Earnings-risk mode

Pre-earnings setup

Wednesday, August 5, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

LLY+0.13%
Sector proxy · XLV+0.51%
Broad market · SPY+0.02%
Same completed session window ending 2026-07-27. LLY was -0.38 points vs XLV. +0.11 points vs SPY.
CatalystUnavailable Stock reactionPositive Sector reactionSupportive Opening surgeUnavailable Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.
Price $1197.53 Jul 27 close
52W High $1249.45 -4.2%
52W Low $623.78
Wks Since High 2w
Base Depth -9.2%
Base B2
SMA 50 $1133.06
SMA 200 $1017.89
Avg Vol 2,968,444
RS Rank 89
RS vs High -2.4%
RS Slope -2.4% ▼
Grp Rank #16/64
ADR% 2.9%
ATR(14) $34.45 (2.9%)
Rel Vol (today) 0.54×
Vol Pace N/A
U/D Vol 0.73
A/D Days 17A / 12D
A/D Rating A+
VDU Bars 0/10 d
Power Trend 3d
Earnings 8d
$623.78
$1249.45 92%

LLY Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for LLY.

Create Free Account
Setup Quality B 4/7 signals
Jul 24: 55 (Cup & Handle)Jul 27: 88 (Cup & Handle)Jul 28: 88 (Cup & Handle)88 Score trend
✓ Stage 2 · Advancing ✗ Power Trend 3d ✗ RS New High ✓ Trend 8/8 ✗ No Pattern ✓ CANSLIM 79.9 (B) ✓ Gatekeeper Base #2 (B)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$LLY · $1197.53 · as of 2026-07-27 · multi-factor read
87
/ 100
Strong Buy

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$1133.06 ↑
100-day$1036.37 ↑
200-day$1017.89 ↑
Bullish (50 > 200)

RSI (14)

Reading57.3 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateWeakening
Histogram-3.320

Weakening — MACD slipped below its signal line. Histogram expanding.

Bollinger Bands (20,2)

%B / Width58% · 8.4%
Squeeze — volatility compressing

Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.73 · Neutral
Rel volume0.54×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $1249.4552-week high
Price · $1197.53now
S · $1134.40swing level
S · $1079.22swing level
S · $1052.15swing level

Fibonacci · Uptrend swing

23.6%$1155.30
38.2%$1097.05
50.0%$1049.98
61.8%$1002.91
78.6%$935.88

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for LLY — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 85 (leader)
Want this read in a legend's voice? 💬 Ask a Legend about LLY
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Minervini
Watch
Minervini A

Trend-template read: 11/12 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $1197.53, MA150 $1041.47, MA200 $1017.89
1.2 150-day MA > 200-day MAMA150 $1041.47 vs MA200 $1017.89
Failing evidence
2. Quarterly EPS growth ≥ 25%+13.4% QoQ
11/12 checks
Method → Playbook → Ask →
O'Neil
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 85
A: Annual earnings & revenue qualityRev +44.7% | ROE 101.3%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+13.4% QoQ
S: Volume ≥ 40% above average on breakoutVolume ratio 0.54x
4/8 checks
Method → Playbook → Ask →
Weinstein
Watch
Weinstein B

Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $1197.53 vs MA200 $1017.89
Failing evidence
Volume expansion above averageVolume ratio 0.54x
6/7 checks
Method → Playbook → Ask →
Livermore
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$1197.53
Relative strengthRS 85
Failing evidence
Volume vs average0.54x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Darvas
Watch
Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$1197.53
Relative strengthRS 85
Failing evidence
Volume vs average0.54x
Box top broken on heavy volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Wyckoff
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$1197.53
Relative strengthRS 85
Failing evidence
Volume vs average0.54x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Method → Playbook → Ask →
Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Follow-Through Tracking
RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
128RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +8 A+
A: 17 D: 9 Net: +865 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini SEPA criteria · 6/7 met
A 6/7 SEPA
Separate score from the 8-point Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ +13%
✓ Revenue growth ≥20% YoY +45%
✓ Gross margin ≥30% 83%
✓ ROE ≥17% 101%
✓ RS rating ≥80 (leadership) 85
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -4.2%

Method Playbook

📋 Trade it like Minervini EXACT LEVELS · PRO
Minervini O'Neil Livermore Weinstein Darvas Wyckoff
Minervini A · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the tight base's structural pivot; the setup must retain Trend Template leadership into the trigger.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a decisive move through the pivot with volume confirmation, and do not initiate more than 5% above it.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start at the tighter structural invalidation; the initial loss limit must not exceed roughly 7–8% from entry.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Hold the initial stop until the trade proves itself; near +1R move to breakeven, then trail a higher low or rising 10/21-day average once well extended.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when the structural stop or a meaningful higher-low/short-term trend violation fires; never widen the stop.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Cup & Handle
88.1 score
RS Score 85
Trend 8/8 ✓
CANSLIM 79.9* (B)
23.5% cup depth 5.6% handle
Why This Setup?
Cup & Handle

depth=23.5%, handle_pb=5.6%, lips_diff=12.4%, upper_half=yes, u_shape=yes, near_pivot=no, orderly=yes | Strong trend (8/8) | Top RS (85) | High-confidence pattern (82%) | Volume drying up (bullish) | Stage 2 | Readiness 73/100 (watch) | CANSLIM 79.9 (B)

Ask a Legend ▾
The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

2/7 universals met
Why these seven? → The Universal Edge

Minervini Trend Template

8/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $1197.53 vs SMA150 $1041.47 / SMA200 $1017.89
SMA 150 above SMA 200 SMA150 $1041.47 vs SMA200 $1017.89
SMA 200 trending up Slope +41.98 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $1133.06
Price above SMA 50 $1197.53 vs SMA50 $1133.06
30%+ above 52W low +92.0% from $623.78
Within 25% of 52W high -4.2% from $1249.45
RS score above 70 RS 85

Fundamentals

52W Range
92%
Mkt Cap SEC
1.1T
EPS QoQ
+13%
Rev YoY
+45%
ROE
101%
Gross Margin
83%
D/E
1.60
EPS TTM
$22.95
P/E TTM
52.2x
Float
942M
Insider
No Buy

Company

Legend AI snapshot
Eli Lilly and Company
LLY · NYSE · Health Technology · Pharmaceuticals: Major
$1197.53latest close $1.1Tmarket cap 89RS rank 88setup score
Track all markets on TradingView
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 79.9* CANSLIM * disqualified on C, M
C · Curr. EPS
75
A · Annual EPS
100
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
85
I · Inst. Spons.
96
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
93
W. Support
$850.51
W. Resist
$1249.45
Weekly Structure

Scan History

20× streak
Jul 24: 55 (Cup & Handle)Jul 27: 88 (Cup & Handle)Jul 28: 88 (Cup & Handle)88
Jul 28
Cup & Handle ✓ Gate
88
Jul 27
Cup & Handle ✓ Gate
88 0.0%
Jul 24
Cup & Handle ✓ Gate
55 +0.1%

Get the full picture on LLY

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial